CEO Saundra Pelletier will present at the H.C. Wainwright Global Life Sciences Conference, providing an update on the commercialization of its non-hormonal, use-it-only-when-you-need-it birth control method, Phexxi® (lactic acid, citric acid and potassium bitartrate) vaginal gel.

The presentation was pre-recorded on March 5, 2021 and will be available for on-demand listening beginning Tuesday, March 9, 2021, at 7:00 a.m. ET.